Q3 2020

Filed Nov 13, 2020 · 10-Q · 44 days after period end · 0001785982-20-000968

Q3 2020 · 10-Q

Revenue—

Net Income

-$202.04K

N/M vs Q3 2019

EPS Diluted

$0.00

N/M vs Q3 2019

Operating Income-$114,448N/M

Operating Cash Flowderived$4,343N/M

Same quarter

Metric	Q3 2020	Q3 2019	Q3 2018	Q3 2017
Revenue	—	—	—	$111.98K
Net Income	-$202.04K	-$874.12K	-$47.52K	$48.88K
EPS Diluted	$0.00	-$0.01	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR